Skip to content

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04947748
Enrollment
100
Registered
2021-07-01
Start date
2020-11-01
Completion date
2021-12-31
Last updated
2021-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Appendicitis, Acute Appendicitis With Appendix Abscess, Acute Appendicitis Without Peritonitis, Acute Appendicitis With Rupture, Appendicitis Acute, Appendicitis Perforated, Appendicitis; Perforation

Brief summary

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous is a prospective randomized controlled trial comparing 24 hour intravenous antibacterial therapy to 24 hour oral antibacterial therapy after surgery in complicated appendicitis.

Interventions

OTHEROral versus intravenous administration of antibacterial treatment

Mode of administration of antibacterial treatment

Sponsors

Tartu University Hospital
CollaboratorOTHER
North Estonia Medical Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

RCT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients diagnosed with acute appendicitis and are candidates for laparoscopic appendectomy.

Exclusion criteria

Patients with compromised immune system (HIV, diabetes), ongoing or completed radio-chemotherapy in past 5 years, prosthetic heart valve, vascular prosthesis, pregnancy.

Design outcomes

Primary

MeasureTime frame
Infectious complications30 days

Countries

Estonia

Contacts

Primary ContactEdgar Lipping, MD
edgar.lipping@regionaalhaigla.ee6171520
Backup ContactSten Saar, MD, PhD
sten.saar@regionaalhaigla.ee6171520

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026